Threshold Pharmaceuticals, Inc.
| Nasdaq: THLD
Threshold Pharmaceuticals, Inc. develops therapeutics for treating tumors. It is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors as novel treatments for patients living with cancer. The company was founded by George Francis Tidmarsh and Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA.